Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Biome Australia Ltd ( (AU:BIO) ) has provided an announcement.
Biome Australia Limited has announced record sales revenue for the fiscal year 2025, achieving approximately $18.4 million, a 41% increase from the previous year. The company also reported its strongest quarter to date, with Q4 sales reaching over $5 million and June sales hitting $2.1 million, marking a 50% increase compared to the previous corresponding period. These results position Biome to meet its Vision 27 forecast of $75 million in cumulative sales for FY25-27, indicating a strong trajectory for future growth.
The most recent analyst rating on (AU:BIO) stock is a Buy with a A$0.85 price target. To see the full list of analyst forecasts on Biome Australia Ltd stock, see the AU:BIO Stock Forecast page.
More about Biome Australia Ltd
Biome Australia Limited is a company focused on microbiome health, offering products that support this sector. Its primary market focus is on domestic growth, with its Activated Probiotics brand leading in its category.
Average Trading Volume: 235,666
Technical Sentiment Signal: Hold
Learn more about BIO stock on TipRanks’ Stock Analysis page.